Quest Diagnostics 2001 Annual Report Download - page 16

Download and view the complete annual report

Please find page 16 of the 2001 Quest Diagnostics annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 20

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20

We improve people’s health by bringing innovative new
tests and technologies to market. Tomorrow’s diagnostic
and predictive tests are being developed today at Quest
Diagnostics—both internally and through collaborations
with others.
At Quest Diagnostics Nichols Institute, our esoteric testing
laboratory and research and development center, scientists
develop and validate new tests that are offered exclusively
by us. For example, we developed in-house the new
ultra-sensitive Heptimax™ viral load test for hepatitis C.
Heptimax helps physicians monitor their patients’
response to therapy and is approximately 10 times more
sensitive than other commercially available tests.
We receive more than 100 million specimens each year
from physicians, hospitals and other clients throughout
the U.S. This unique breadth of experience affords
us access to a wide range of clinical situations, and makes
Quest Diagnostics an ideal partner for those working
to bring new diagnostic technologies to market, from
global diagnostics manufacturers to biotech discovery
firms to academic researchers.
Our significant research and development agreement
with Roche Diagnostics, a world leader in diagnostic
testing instrumentation and reagents, will focus on
developing new exclusive tests for stroke and asthma
patients. Together, we will share in the benefits of
bringing other new gene-based testing products to
market based on Roche’s polymerase chain reaction
(PCR) technology. Gene-based testing improves health
by making tests more accurate, personalized and
predictive. We are the leader in gene-based medical
INNOVATIVE TECHNOLOGY
Quest Diagnostics is the leader in
gene-based medical testing.
14
Nichols Institute esoteric testing laboratory and R&D center. Sophisticated equipment enables the highest accuracy.